Patents by Inventor Saraswathy V. Nochur

Saraswathy V. Nochur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9127277
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: September 8, 2015
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Akshay Vaishnaw, Saraswathy V. Nochur, Sayda Elbashir, Muthiah Manoharan, Rachel Meyers
  • Publication number: 20130165499
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets.
    Type: Application
    Filed: February 27, 2013
    Publication date: June 27, 2013
    Inventors: Akshay Vaishnaw, Saraswathy V. Nochur, Sayda Elbashir, Muthiah Manoharan, Rachel Meyers
  • Patent number: 8410073
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA comprises a sense strand of ALN-RSV01 and an antisense strand of ALN-RSV01.
    Type: Grant
    Filed: January 26, 2012
    Date of Patent: April 2, 2013
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Akshay Vaishnaw, Saraswathy V. Nochur, Sayda Elbashir, Muthiah Manoharan, Rachel Meyers
  • Publication number: 20120189555
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA comprises a sense strand of ALN-RSV01 and an antisense strand of ALN-RSV01.
    Type: Application
    Filed: January 26, 2012
    Publication date: July 26, 2012
    Inventors: Akshay Vaishnaw, Saraswathy V. Nochur, Sayda Elbashir, Muthiah Manoharan, Rachel Meyers
  • Publication number: 20090238772
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA comprises a sense strand of ALN-RSV01 and an antisense strand of ALN-RSV01.
    Type: Application
    Filed: December 15, 2008
    Publication date: September 24, 2009
    Applicant: Alnylam Pharmaceuticals, Inc.
    Inventors: Akshay Vaishnaw, Saraswathy V. Nochur, Sayda Elbashir, Muthiah Manoharan, Rachel Meyers